Previous 10 | Next 10 |
Assuming no COVID-19 cancellations, here is a list of noteworthy events during the week of March 15 - 21 for healthcare investors: More news on: Eton Pharmaceuticals, Inc., Vertex Pharmaceuticals Incorporated, Arcutis Biotherapeutics, Inc., Healthcare stocks news, , Read more ...
DEER PARK, Ill., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that it will report fourth quarter and full year 2019 financial and operating r...
I was checking out companies with upcoming PDUFA dates and Eton ( ETON ) grabbed my attention. It has a March 17, 2020 PDUFA date for its patent-pending formulation of lamotrigine in treatment of certain seizures. It also has several other near term catalysts. As such it has earned my a...
Today, we will study why Eton Pharmaceuticals (ETON) is an attractive pick in 2020. Company overview Founded in 2017 with a $20 million financing, Eton Pharmaceuticals is a specialty pharmaceutical company focused mainly on opportunities in the hospital and pediatric settings. The compan...
Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...
Thinly traded micro cap Eton Pharmaceuticals ( ETON -11.7% ) is down on almost triple normal volume, a modest 177K shares, in response to its update on its U.S. marketing application for ET-105, currently under FDA review. More news on: Eton Pharmaceuticals, Inc., Healthcare stocks new...
Groupon (NASDAQ: GRPN ) -31% on Q4 earnings . More news on: Groupon, Inc., Scientific Games Corporation, Blue Apron Holdings, Inc., Stocks on the move, , Read more ...
DEER PARK, Ill., Feb. 19, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today provided an update on its ET-105 product candidate, which is currently under review with ...
DEER PARK, Ill., Feb. 13, 2020 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (NASDAQ: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative drug products, today announced that Sean Brynjelsen, Chief Executive Officer, will present at the 9th Annual ...
Eton Pharmaceuticals (NASDAQ: ETON ) has entered into a co-promotion agreement with Xellia Pharmaceuticals for the promotion of Biorphen (phenylephrine HCl), an only FDA approved ready-to-use formulation of phenylephrine injection indicated for the treatment of hypotension resulting p...
News, Short Squeeze, Breakout and More Instantly...
Eton Pharmaceutcials Inc. Company Name:
ETON Stock Symbol:
NASDAQ Market:
Eton Pharmaceutcials Inc. Website:
- Prescription Drug User Fee Act (PDUFA) target action date is February 28, 2025 - - Product has patent protection through 2043 - DEER PARK, Ill., July 15, 2024 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innov...
• Q1 2024 revenue of $8.0 million, representing 50% growth over Q1 2023 and the 13 th straight quarter of sequential product sales growth • Acquired PKU GOLIKE®, launched Nitisinone, and submitted a new drug application (NDA) for product candidate ET...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...